Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Medical Devices

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by Redbaron2211on May 02, 2019 1:32am

110 Views

Post# 29698899

RE:RE:RE:RE:RE:RE:RE:RE:Sernova's Thyroid news today is about "da pouch"

Bio I do believe that Pharma is on the sidelines waiting to scoop this up. I don't see where you get such high failure rates from as currently this device has only been proven to be successful, now with a very talented team and purified islets the chances of success are even higher.

Pharma wants more then the Shapiro trial to prove this works and we are on the verge of catalysts that could seal a deal.

Hope you are able to pick up some more.

Bullboard Posts

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal